Table 1 Diagnostic criteria and prevalence for hyperuricemia in each country/area
From: Hyperuricemia and its related diseases: mechanisms and advances in therapy
Country/area | Male | Female | General | Prevalence |
|---|---|---|---|---|
United States | 7.0 mg/dL (420 µmol/L) | 6.0 mg/dL (360 µmol/L) | 7.0 mg/dL (420 µmol/L) | 21%35 |
Japan | 7.0 mg/dL (420 µmol/L) | 6.0 mg/dL (360 µmol/L) | / | 30% in male and 3% in female440 |
United Kingdom | 6.8 mg/dL (404 µmol/L) | 6.0 mg/dL (360 µmol/L) | / | 27.72% in male and 10.69% in female336 |
India | / | / | 7.0 mg/dL (420 µmol/L) | 44.6%48 |
European Union | 6.8 mg/dL (404 µmol/L) | 5.7 mg/dL (339 µmol/L) | / | 11.9%–25.0% of the European population336 |
China | 7.0 mg/dl (420.0 μmol/l) | 6.0 mg/dl (360.0 μmol/l) | 7.0 mg/dL (420 µmol/L) | 17.7%54 |
Australia | / | / | 7.0 mg/dL (420 µmol/L) | 16.6%36 |
Finland | 6.8 mg/dL (404 µmol/L) | 5.7 mg/dL (339 µmol/L) | / | 48.0% (60% in male and 31% in female)37 |
New Zealand | / | / | 7.0 mg/dL (420 µmol/L) | 17.0% (27.8% in male and 8.8% in female)38 |
Ireland | 6.8 mg/dL (404 µmol/L) | 5.7 mg/dL (339 µmol/L) | / | 24.5% (25.0% in male and 24.1% in female)39 |
Croatia | 6.8 mg/dL (404 µmol/L) | 5.7 mg/dL (339 µmol/L) | / | 9.9%40 |
Russia | / | / | 7.0 mg/dL (420 µmol/L) | 16.8%41 |
Turkey | 7.0 mg/dl (420.0 μmol/l) | 6.0 mg/dl (360.0 μmol/l) | 7.0 mg/dL (420 µmol/L) | 12.1% (19.0% in male and 5.8% in female)42 |
Qatar | / | / | 7.0 mg/dL (420 µmol/L) | 21.2%43 |
Korea | 7.0 mg/dl (420.0 μmol/l) | 6.0 mg/dl (360.0 μmol/l) | 7.0 mg/dL (420 µmol/L) | 11.4% (17.0% in male and 5.9% in female)44 |
Mexico | / | / | 7.0 mg/dL (420 µmol/L) | 20.6%45 |
Niger | / | / | 7.0 mg/dL (420 µmol/L) | 17.2%46 |
French Polynesia | / | / | 6.0 mg/dL (360 µmol/L) | 71.6%47 |
Jordan | / | / | 7.0 mg/dL (420 µmol/L) | 28.1%49 |
sub-Saharan African | / | / | 6.0 mg/dL (360 µmol/L) | 31.8%50 |
Thailand | 7.0 mg/dl (420.0 μmol/l) | 6.0 mg/dl (360.0 μmol/l) | 7.0 mg/dL (420 µmol/L) | 10.6% (18.4% in male and 7.8% in female)51 |
Saudi Arabia | 7.0 mg/dL (420 µmol/L) | 6.0 mg/dL (360 µmol/L) | 7.0 mg/dL (420 µmol/L) | 8.4%52 |
Bangladesh | 7.0 mg/dl (420.0 μmol/l) | 6.0 mg/dl (360.0 μmol/l) | 7.0 mg/dL (420 µmol/L) | 9.3%53 |
